| Literature DB >> 32047643 |
Nicole M Robertson1,2, Alex Kayongo3, Trishul Siddharthan1,2, Suzanne L Pollard1,2, Jose Gomez Villalobos4, Christine Ladd-Acosta5, Bruce Kirenga6, William Checkley1,2.
Abstract
As urbanization increases in low- and middle-income countries (LMICs), urban populations will be increasingly exposed to a range of environmental risk factors for non-communicable diseases. Inadequate living conditions in urban settings may influence mechanisms that regulate gene expression, leading to the development of non-communicable respiratory diseases. We conducted a systematic review of the literature to assess the relationship between respiratory health and epigenetic factors to urban environmental exposures observed in LMICs using MEDLINE, PubMed, EMBASE, and Google Scholar searching a combination of the terms: epigenetics, chronic respiratory diseases (CRDs), lung development, chronic obstructive airway disease, and asthma. A total of 2835 articles were obtained, and 48 articles were included in this review. We found that environmental factors during early development are related to epigenetic effects that may be associated with a higher risk of CRDs. Epigenetic dysregulation of gene expression of the histone deacetylase (HDAC) and histone acetyltransferase gene families was likely involved in lung health of slum dwellers. Respiratory-related environmental exposures influence HDAC function and deoxyribonucleic acid methylation and are important risk factors in the development of CRD. Additional epigenetic research is needed to improve our understanding of associations between environmental exposures and non-communicable respiratory diseases.Entities:
Keywords: Chronic respiratory diseases; epigenetics; low and middle-income countries; slum dwellers
Mesh:
Year: 2019 PMID: 32047643 PMCID: PMC6983949 DOI: 10.1017/gheg.2019.7
Source DB: PubMed Journal: Glob Health Epidemiol Genom ISSN: 2054-4200
Fig. 1.Literature search process to identify papers to include in this review.
Example of NOS for assessment of quality of included studies-cross-sectional studies (1 indicates individual criterion within the subsection was fulfilled)
| Quality assessment criteria | White | Waterland | Ezzie | Kohli |
|---|---|---|---|---|
| Selection (maximum 4) | ||||
| Case definition adequate | 1 | 1 | 1 | 1 |
| Representativeness of the cases | 1 | 1 | 1 | 1 |
| Selection of controls | 1 | 1 | 1 | 1 |
| Definition of controls | 1 | 1 | 0 | 1 |
| Comparability (maximum 2) | ||||
| Comparability of cohorts on the basis of the design of analysis (controls used) | 1 | 1 | 1 | 1 |
| Confounding factors are controlled. | 1 | 1 | 1 | 1 |
| Exposure (maximum 3) | ||||
| Ascertainment of exposure | 1 | 1 | 1 | 1 |
| Same method cases and controls? | 1 | 1 | 1 | 1 |
| Non-response rate | 0 | 1 | 0 | 0 |
| Overall quality score (maximum 9) | 8 | 9 | 7 | 8 |
Results of the relationship between epigenetic factors and lung health in included studies in this systematic literature review
| Epigenetic factors | Activity in asthma, COPD, or smoking | Reference | Sample size | Type of sample | Country |
|---|---|---|---|---|---|
| Class 1 HDAC Family | |||||
| HDAC 1 | Decreased in asthma, not yet studied in smoking and COPD patients | [ | 40 | Bronchial biopsy samples | UK |
| [ | 28 | Alveolar macrophages | UK | ||
| [ | 24 | Rat lung tissue | UK | ||
| HDAC 2 | Decreased in asthma, smoking and COPD | [ | 40 | Bronchial biopsy samples | UK |
| [ | 28 | Alveolar macrophages | UK | ||
| [ | 24 | Rat lung tissue | UK | ||
| [ | 29 | Human bronchial biopsies | UK | ||
| HDAC 3 and 8 | Decreased in COPD, no difference in asthma, limited published data in smoking | [ | 28 | Alveolar macrophages | UK |
| [ | 159 | Human lung tissue | USA and Canada | ||
| Class II HDAC family | |||||
| HDAC 5 | Decreased in COPD, no difference in asthma, limited published data in smoking | [ | 28 | Alveolar macrophages | UK |
| [ | 159 | Human lung tissue | USA and Canada | ||
| Class III HDAC family | |||||
| SIRT1 | Limited published data | ||||
| Class IV HDAC family | |||||
| HDAC 11 | Limited published data | ||||
| GNATs-HAT family | |||||
| HAT1, GCN5, GCN5L, Elp3, PCAF | Increased in asthma patients, limited published data on smoking and COPD | [ | 40 | Bronchial biopsy samples | UK |
| [ | – | Cell culture-mature monocytes | USA | ||
| General transcription factor-HATs | |||||
| TAF250, TFIIIC | Increased in asthma, limited published data on smoking and COPD | [ | 40 | Bronchial biopsy samples | UK |
| [ | 28 | Alveolar macrophages | UK | ||
HDAC, histone deacetylase; SIRT1, sirtuin; HAT, histone acetyl transferase; GCN5, general control of amino acid synthesis protein 5; GCN5L, general control of amino acid synthesis protein 5 ligand; Elp3, elongation complex protein; PCAF, protein300/CREB-binding protein-associated factor; TAF250, TBP-associated factor 250 kDa; TFIIIC, transcription factors IIIC.